Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer.
Year: 1996
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: E J Small, S Srinivas, B Egan, A McMillan, T P Rearden
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2238819470